Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 181, pseudogene (RN7SL181P)

Target
RN7SL181P
Molecular classification
Other (Pseudogene), Long non-coding RNA (lncRNA pseudogene)
01

Overview

RNA, 7SL, cytoplasmic pseudogene 181 (RN7SL181P) is a human genomic pseudogene derived from the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP) responsible for co-translational protein targeting to the endoplasmic reticulum. The pseudogene is a non-functional, sequence-similar copy of the 7SL RNA gene, harboring mutations or truncations that preclude its normal expression or function. While canonical 7SL RNA (not pseudogene) is a well-described lncRNA with architectural roles in SRP assembly and viral packaging processes, pseudogenes like RN7SL181P typically lack any known biological or disease role and are not considered drug targets nor molecular biomarkers. Evidence suggests some pseudogenes can act as decoys or regulatory elements in rare cases, but there is no documentation of biological activity for RN7SL181P specifically.

Other names
RN7SL181P7SL RNA pseudogene 181RNA, 7SL, cytoplasmic 181
02

Mechanism of action

None relevant; pseudogenes do not encode functions for canonical drug mechanisms

03

Biological functions

None known; pseudogenes generally do not perform canonical functions unless expressed with regulatory impact
04

Disease associations

None established; no known direct association with disease for this specific pseudogene.
05

Safety considerations

None reported; pseudogenes do not present safety concerns as drug targets.
06

Interacting drugs

None known; pseudogenes are not direct drug targets in current pharmacology.
07

Biomarkers

None known; not used as a biomarker for patient selection or efficacy.

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 181, pseudogene (RN7SL181P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 181, pseudogene (RN7SL181P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call